Elspar and Pneumonia - a phase IV clinical study of FDA data

Summary:

Pneumonia is reported as a side effect among people who take Elspar (asparaginase), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Methotrexate, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Pneumonia when taking Elspar. It is created by eHealthMe based on reports of 2,053 people who have side effects when taking Elspar from the FDA, and is updated regularly.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users. Check the latest studies of Elspar.

What is Pneumonia?

Pneumonia is found to be associated with 3,353 drugs and 4,677 conditions by eHealthMe. Check the latest studies of Pneumonia.

On Jul, 16, 2026

2,053 people reported to have side effects when taking Elspar.
Among them, 56 people (2.73%) have Pneumonia.

Among these 56 people:

How long have people been on Elspar when they have Pneumonia? *

What is the gender of people who have Pneumonia when taking Elspar? *

female: 60.78 %
male: 39.22 %

What is the age of people who have Pneumonia when taking Elspar? *

What are other drugs people take besides Elspar? *

What are other side effects people have besides Pneumonia? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 17.86%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 14.29%
Fever: 7 people, 12.50%
Myositis (inflammation of the muscles): 6 people, 10.71%
Cerebral Haemorrhage (bleeding within the brain): 6 people, 10.71%
Thrombocytopenia (decrease of platelets in blood): 6 people, 10.71%
Heart Attack: 5 people, 8.93%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 8.93%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 8.93%
Mucosal Inflammation (infection of mucous membrane): 5 people, 8.93%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 32 people, 57.14%
B Precursor Type Acute Leukaemia (lymphoid cancer): 4 people, 7.14%
Extranodal Nk/t-Cell Lymphoma, Nasal Type (lymphoid cancer): 3 people, 5.36%
T-Cell Lymphoma Stage Iv (one or more organs beyond the lymph nodes are affected with cancer of lymph node): 1 person, 1.79%
T-Cell Lymphoma (a blood cell cancer): 1 person, 1.79%
Stress And Anxiety: 1 person, 1.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.79%
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly): 1 person, 1.79%
Pain: 1 person, 1.79%
Nausea (feeling of having an urge to vomit): 1 person, 1.79%

* Approximation only. Some reports may have incomplete information.

Do you take Elspar and have Pneumonia?

- Check whether Pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elspar:

Elspar (2,057 reports)

Pneumonia treatments and more:

Pneumonia (433,139 reports)

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia:

Pneumonia (3,353 drugs)

Browse all the conditions that are associated with Pneumonia:

Pneumonia (4,677 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asparaginase (the active ingredients of Elspar) and Elspar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.